XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.3
Note 8 - Earnings Per Share
 9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Earnings Per Share [Text Block]

Note 8 – Earnings per Share

 

Basic net income per share is computed based on the weighted average number of common shares outstanding for each period presented. Diluted net income per share reflects the potential dilution that would have occurred if securities to issue common stock were exercised, converted, or resulted in the issuance of common stock that would have then shared in our earnings.

 

The following table summarizes the earnings and the weighted average number of common shares used in the calculation of basic and diluted earnings per share (in thousands, except for share and per share amounts):

 

  

Three Months Ended
September 30

  

Nine Months Ended
September 30

 
  

2025

  

2024

  

2025

  

2024

 

Basic:

                

Weighted average common shares outstanding

  15,484,464   15,411,680   15,461,804   15,384,758 

Net income attributable to National HealthCare Corporation

 $39,239  $42,789  $95,166  $95,846 

Earnings per common share, basic

 $2.53  $2.78  $6.15  $6.23 
                 

Diluted:

                

Weighted average common shares outstanding

  15,484,464   15,411,680   15,461,804   15,384,758 

Effects of dilutive instruments

  180,066   255,641   151,701   191,536 

Weighted average common shares outstanding

  15,664,530   15,667,321   15,613,505   15,576,294 
                 

Net income attributable to National HealthCare Corporation

 $39,239  $42,789  $95,166  $95,846 

Earnings per common share, diluted

 $2.50  $2.73  $6.10  $6.15 

 

For the three and nine months ended September 30, 2025, 6,450 stock options were excluded from the calculation of diluted weighted average shares of common stock outstanding because the inclusion of these securities would have an anti-dilutive impact. For the three and nine months ended September 30 2024, we did not exclude any stock options from the calculation of diluted weighted average shares of common stock outstanding because the inclusion of these securities would have an anti-dilutive effect.